A Multicenter, Randomized, Double-blind, Placebo-controlled, 12-week Treatment, Parallel-group Study to Assess the Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate (75 and 150 µg o.d.) in Patients With Persistent Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, 12-week Treatment, Parallel-group Study to Assess the Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate (75 and 150 µg o.d.) in Patients With Persistent Asthma
To provide the efficacy, safety and pharmacokinetics of indacaterol acetate in patients with persistent asthma to support dose selection of indacaterol in fixed dose combination QMF149.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Ste-Foy, Quebec G1W 4R4, Canada
Ako-shi, Hyōgo 678-0241, Japan
Naka-gun, Ibaraki 319-1113, Japan
Chuo-ku, Tokyo 103-0027, Japan
Cyuo-ku, Tokyo 104-8560, Japan
Itabashi-ku, Tokyo 173-8610, Japan
Setagaya-ku, Tokyo 158-0097, Japan
Machida-shi, Tokyo-To 194-0023, Japan
Sittard-Geleen, 6162 BG, Netherlands
Spisská Nová Ves, 052 01, Slovakia